Accelerometer Medical Sensors Industry Will Advance at a 14.4% CAGR

The accelerometer medical sensors market was USD 4,111.5 million in 2023, which will rise to USD 10,442.9 million, advancing at a 14.4% compound annual growth rate, by 2030.

To learn more about this report: https://bit.ly/3tzwyc6

This growth is mainly driven by the rising need for nonstop monitoring of health; physiological sensors miniaturization; and enhanced functions, cost-effectiveness, and ease of operation of these devices.

Furthermore, this growth is also assisted by the surging populace with high disposable salaries, which suggests they can easily spend money on developed technologies.

The wearables category, on the basis of products, is the major contributor to the industry. This can be because it is employed for measuring different factors of health like blood pressure, heart rate, and carbon dioxide level. The measurement of such factors assists healthcare professionals as well as researchers in gaining responses and providing greater treatment.

The hospitals & clinics category, on the basis of end user, is the major contributor to the industry. This can be because of the speedy acceptance of developed technologies, easy treatment availability and affordability, the existence of experienced specialists in these healthcare facilities, and the large patient pool.

Furthermore, the existence of numerous hospitals and the rising healthcare spending in both developing and developed nations like China, the U.S., and the U.K., and various chronic illness-associated surgeries are conducted in hospitals, which boosts the expansion of this category.

The chronic illness & risk monitoring category, on the basis of application, is leading the accelerometer medical sensors market. This is primarily because of the rising occurrence of cancer, cardiovascular illnesses, and other illnesses. The key causes of these illnesses comprise smoking and tobacco consumption, unhealthy dietary habits, and obesity. 

Moreover, the wellness monitoring category will propel at the fastest compound annual growth rate in the years to come. This is primarily because of the monitoring or tracking of health care parameters in a digital setting using sensor-based devices, which assists in monitoring movement as well as intensity.

North America is the largest contributor to the industry, and it is likely to remain the largest, generating USD 1.8 billion in 2030. This can be mainly because of the well-established healthcare system, coupled with the high disposable salary in this continent.

APAC is likely to be a significant contributor to the industry in 2030. This will be mainly attributed to the increasing unhealthy lifestyle among people, the surging aging populace, the rising incidence of cardiovascular illnesses, and the growing acceptance of developed technologies.

It is because of the rise in awareness about health and fitness, the accelerometer medical sensors industry will continue to grow significantly in the years to come.

Read More

DNA Synthesizer Market Led by Biotech Companies

The DNA synthesizer market was valued at USD 266.3 million in 2023, which will reach USD 686.1 million by 2030, rising at a rate of 14.6% by the end of this decade. This is attributed to the rising occurrence of chronic diseases, growing requirement for more-personalized therapies, expanding acceptance of gene therapy, and growing investments in R&D.

Recently, there has been a drastic increase in the prevalence of severe chronic ailments, for example immunological ailments, cancer, and genetic illnesses, all over the globe.

Nearly 50,000 congenital disorders that are an outcome of a mutation of a single gene are recognized by scientists. This is powering the acceptance of gene therapy, as it can cure severe ailments that were previously untreatable, and the outcomes are better than expected. For example, numerous people have already regained their vision with the help of gene therapy, after suffering from hereditary, gradual blindness.

Based on end user, biotech companies led the industry, with a share of 50%, in 2023. This is due to the growing biotech-related research, powered by the increasing requirement for biologic drugs, for example vaccines.

Essentially, the increasing incidence of chronic ailments has powered regional administrations to spend on life science projects so that scientists can do more-efficient treatment, substantial investments but also tech progressions, which has boosted the count of novel therapeutics becoming obtainable to patients at a global level. 

It is because of the increasing acceptance of gene therapy all over the world, the demand for DNA synthesizer is on the rise. This trend will also continue in the years to come as well.

Read More